𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemia

✍ Scribed by DeAngelo, Daniel J.; Neuberg, Donna; Amrein, Philip C.; Berchuck, Jacob E.; Wadleigh, Martha; Sirulnik, L. Andres; Galinsky, Ilene; Golub, Todd; Stegmaier, Kimberly; Stone, Richard M.


Book ID
122217904
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
675 KB
Volume
38
Category
Article
ISSN
0145-2126

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES